Capnocytophaga canimorsus

From WikiMD's WELLNESSPEDIA

Capnocytophaga canimorsus is a gram-negative, rod-shaped bacterium that is commonly found in the microflora of the canine and feline oral cavity. It is known to cause severe illness in humans, particularly those with weakened immune systems or those who have been bitten by a dog or cat.

Characteristics[edit]

Capnocytophaga canimorsus is a facultative anaerobe, meaning it can grow in both the presence and absence of oxygen. It is also catalase-positive and oxidase-positive, which are important characteristics for its identification in the laboratory.

Pathogenesis[edit]

Capnocytophaga canimorsus is a rare cause of sepsis, meningitis, endocarditis, and other severe infections in humans. These infections are often associated with dog or cat bites, hence the species name canimorsus, which means "dog-biter". The bacterium can enter the bloodstream through the bite wound and cause a systemic infection.

Diagnosis and Treatment[edit]

Diagnosis of Capnocytophaga canimorsus infection is typically made by blood culture, although it can be difficult to grow in the laboratory due to its slow growth rate and fastidious nature. Treatment usually involves antibiotics, with penicillin and cephalosporin being the most commonly used.

Prevention[edit]

Prevention of Capnocytophaga canimorsus infection involves avoiding dog and cat bites, particularly for those with weakened immune systems. In the event of a bite, immediate medical attention should be sought to clean and treat the wound.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.